<DOC>
	<DOCNO>NCT01780974</DOCNO>
	<brief_summary>The primary aim pilot study provide data use good determine sample size design large clinical trial . The pilot evaluate effectiveness Lipoic Acid ( LA ) plus Omega-3 fatty acid ( Omega-3 ) prevent Alzheimer 's Disease ( AD ) . The investigator also collect data evaluate recruitment rate , safety , compliance 12 month study period .</brief_summary>
	<brief_title>Pilot Study : Lipoic Acid Omega-3 Fatty Acids Alzheimer 's Prevention</brief_title>
	<detailed_description>The primary aim collect data determine effect size lipoic acid plus omega-3 fatty acid placebo primary outcome measure Trails B ( executive function ) . This design pilot randomize , double-blind , placebo-controlled study 12 month intervention period . Thirty participant diagnose hypertension treat ( systolic blood pressure 90-160 mm Hg , diastolic blood pressure 60-90 mm Hg ) low omega-3 fatty acid level , normal cognitive function randomize receive study drug placebo .</detailed_description>
	<mesh_term>Hypertension</mesh_term>
	<mesh_term>Thioctic Acid</mesh_term>
	<criteria>55 year old Nondemented : Montreal Cognitive Assessment &gt; 26 Clinical Dementia Rating = 0 Diagnosis Essential Hypertension systolic 90160 mm Hg diastolic 6090 mm Hg Stable dose antihypertensive medication 4 month prior study enrollment Stable dose lipid lower medication dose must stable 4 month prior study enrollment Low Omega3 fatty acid Status : Omega3 index , &lt; 4 % total fatty acid combine docosahexaenoic acid eicosapentanoic acid Geriatric Depression Scale &lt; 5 General health status interfere participant 's ability complete study . Screening laboratory value within normal limit , abnormal , deem clinically insignificant investigator Sufficient English language skill complete test Alzheimer 's , Dementia neurodegenerative disease . Health condition cancer diagnose &lt; 5 year prior enrollment ( prostate cancer gleason grade &lt; 3 non metastatic skin cancer acceptable ) , liver disease , history ventricular fibrillation ventricular tachycardia , major psychiatric disorder , central nervous system disease ( e.g . brain tumor , seizure disorder ) Insulin dependent diabetes uncontrolled diabetes ( diabetes control medication insulin acceptable ) Fish intake one 6 ounce serve &gt; week le 4 month prior enrollment Omega3 fatty acid supplement intake ( e.g . fish oil capsule , cod liver oil ) less 4 month prior enrollment Lipoic Acid supplementation le 1 month prior enrollment Taking systemic corticosteroid , neuroleptic , antiparkinsonian agent , and/or narcotic analgesic . Low dose sinemet dopamine agonist take day restless leg syndrome exclusion . Contraindications MRI , include : subject intrathecal pump , stimulators , pacemaker , aneurysm clip , nonremovable hearing aid , metal fragment eye . Other exclusion criterion include inability lie flat back 40 minute time selfreported history claustrophobia . Subjects history hip replacement welldocumented , verifiable , MRIsafe cardiac stent exclude study . Enrollment another treatment study</criteria>
	<gender>All</gender>
	<minimum_age>55 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>February 2017</verification_date>
	<keyword>Hypertension</keyword>
	<keyword>Vascular Risk</keyword>
	<keyword>Alzheimer 's Risk</keyword>
	<keyword>fish oil</keyword>
	<keyword>Lipoic acid</keyword>
</DOC>